世界の抗真菌感染症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Antifungal infection Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0387 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、抗真菌感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ポリエン、エキノカンジン、アゾール、アリルアミン、その他薬剤種類）、用途別市場規模（粉末、ペースト、軟膏、医薬品、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・抗真菌感染症治療の市場動向 ・企業の競争状況、市場シェア ・抗真菌感染症治療の種類別市場規模（ポリエン、エキノカンジン、アゾール、アリルアミン、その他薬剤種類） ・抗真菌感染症治療の用途別市場規模（粉末、ペースト、軟膏、医薬品、その他） ・抗真菌感染症治療の北米市場規模2016-2027（アメリカ、カナダ） ・抗真菌感染症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・抗真菌感染症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・抗真菌感染症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・抗真菌感染症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Scynexis、Sanofi-Aventis、Pfizer、Novartis、Merck & Co、Kramer Laboratories、Johnson & Johnson、ID Sigma-Aldrich Corporation、Glenmark Pharmaceuticals、Glaxosmithkline、Enzon Pharmaceuticals、Bayer Healthcare、Astellas Pharma、Asperqillus、Alternaria、Abbott Laboratories） ・結論

Antifungal drugs are used to treat infections caused by fungus and to prevent the development of fungal infections in patients with weakened immune systems.

Market Analysis and Insights: Global Antifungal infection Therapeutics Market
The global Antifungal infection Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antifungal infection Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antifungal infection Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antifungal infection Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antifungal infection Therapeutics market.

Global Antifungal infection Therapeutics Scope and Market Size
Antifungal infection Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antifungal infection Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Polyenes
Echinocandins
Azoles
Allylamines
Other Drug types

Segment by Application
Powders
Pastes
Ointments
Drugs
Other Applications

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Scynexis
Sanofi-Aventis
Pfizer
Novartis
Merck & Co
Kramer Laboratories
Johnson & Johnson
ID Sigma-Aldrich Corporation
Glenmark Pharmaceuticals
Novartis
Merck & Co
Bayer Healthcare
Astellas Pharma
Asperqillus

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antifungal infection Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Polyenes
1.2.3 Echinocandins
1.2.4 Azoles
1.2.5 Allylamines
1.2.6 Other Drug types
1.3 Market by Application
1.3.1 Global Antifungal infection Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Powders
1.3.3 Pastes
1.3.4 Ointments
1.3.5 Drugs
1.3.6 Other Applications
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Antifungal infection Therapeutics Market Perspective (2016-2027)
2.2 Antifungal infection Therapeutics Growth Trends by Regions
2.2.1 Antifungal infection Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Antifungal infection Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Antifungal infection Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Antifungal infection Therapeutics Industry Dynamic
2.3.1 Antifungal infection Therapeutics Market Trends
2.3.2 Antifungal infection Therapeutics Market Drivers
2.3.3 Antifungal infection Therapeutics Market Challenges
2.3.4 Antifungal infection Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Antifungal infection Therapeutics Players by Revenue
3.1.1 Global Top Antifungal infection Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Antifungal infection Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Antifungal infection Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antifungal infection Therapeutics Revenue
3.4 Global Antifungal infection Therapeutics Market Concentration Ratio
3.4.1 Global Antifungal infection Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antifungal infection Therapeutics Revenue in 2020
3.5 Antifungal infection Therapeutics Key Players Head office and Area Served
3.6 Key Players Antifungal infection Therapeutics Product Solution and Service
3.7 Date of Enter into Antifungal infection Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Antifungal infection Therapeutics Breakdown Data by Type
4.1 Global Antifungal infection Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Antifungal infection Therapeutics Forecasted Market Size by Type (2022-2027)

5 Antifungal infection Therapeutics Breakdown Data by Application
5.1 Global Antifungal infection Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Antifungal infection Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Antifungal infection Therapeutics Market Size (2016-2027)
6.2 North America Antifungal infection Therapeutics Market Size by Type
6.2.1 North America Antifungal infection Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Antifungal infection Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Antifungal infection Therapeutics Market Size by Type (2016-2027)
6.3 North America Antifungal infection Therapeutics Market Size by Application
6.3.1 North America Antifungal infection Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Antifungal infection Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Antifungal infection Therapeutics Market Size by Application (2016-2027)
6.4 North America Antifungal infection Therapeutics Market Size by Country
6.4.1 North America Antifungal infection Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Antifungal infection Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Antifungal infection Therapeutics Market Size (2016-2027)
7.2 Europe Antifungal infection Therapeutics Market Size by Type
7.2.1 Europe Antifungal infection Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Antifungal infection Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Antifungal infection Therapeutics Market Size by Type (2016-2027)
7.3 Europe Antifungal infection Therapeutics Market Size by Application
7.3.1 Europe Antifungal infection Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Antifungal infection Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Antifungal infection Therapeutics Market Size by Application (2016-2027)
7.4 Europe Antifungal infection Therapeutics Market Size by Country
7.4.1 Europe Antifungal infection Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Antifungal infection Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Antifungal infection Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Antifungal infection Therapeutics Market Size by Type
8.2.1 Asia-Pacific Antifungal infection Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Antifungal infection Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Antifungal infection Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Antifungal infection Therapeutics Market Size by Application
8.3.1 Asia-Pacific Antifungal infection Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Antifungal infection Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Antifungal infection Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Antifungal infection Therapeutics Market Size by Region
8.4.1 Asia-Pacific Antifungal infection Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Antifungal infection Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Antifungal infection Therapeutics Market Size (2016-2027)
9.2 Latin America Antifungal infection Therapeutics Market Size by Type
9.2.1 Latin America Antifungal infection Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Antifungal infection Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Antifungal infection Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Antifungal infection Therapeutics Market Size by Application
9.3.1 Latin America Antifungal infection Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Antifungal infection Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Antifungal infection Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Antifungal infection Therapeutics Market Size by Country
9.4.1 Latin America Antifungal infection Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Antifungal infection Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Antifungal infection Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Antifungal infection Therapeutics Market Size by Type
10.2.1 Middle East & Africa Antifungal infection Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Antifungal infection Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Antifungal infection Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Antifungal infection Therapeutics Market Size by Application
10.3.1 Middle East & Africa Antifungal infection Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Antifungal infection Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Antifungal infection Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Antifungal infection Therapeutics Market Size by Country
10.4.1 Middle East & Africa Antifungal infection Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Antifungal infection Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Scynexis
11.1.1 Scynexis Company Details
11.1.2 Scynexis Business Overview
11.1.3 Scynexis Antifungal infection Therapeutics Introduction
11.1.4 Scynexis Revenue in Antifungal infection Therapeutics Business (2016-2021)
11.1.5 Scynexis Recent Development
11.2 Sanofi-Aventis
11.2.1 Sanofi-Aventis Company Details
11.2.2 Sanofi-Aventis Business Overview
11.2.3 Sanofi-Aventis Antifungal infection Therapeutics Introduction
11.2.4 Sanofi-Aventis Revenue in Antifungal infection Therapeutics Business (2016-2021)
11.2.5 Sanofi-Aventis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Antifungal infection Therapeutics Introduction
11.3.4 Pfizer Revenue in Antifungal infection Therapeutics Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Antifungal infection Therapeutics Introduction
11.4.4 Novartis Revenue in Antifungal infection Therapeutics Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Merck & Co
11.5.1 Merck & Co Company Details
11.5.2 Merck & Co Business Overview
11.5.3 Merck & Co Antifungal infection Therapeutics Introduction
11.5.4 Merck & Co Revenue in Antifungal infection Therapeutics Business (2016-2021)
11.5.5 Merck & Co Recent Development
11.6 Kramer Laboratories
11.6.1 Kramer Laboratories Company Details
11.6.2 Kramer Laboratories Business Overview
11.6.3 Kramer Laboratories Antifungal infection Therapeutics Introduction
11.6.4 Kramer Laboratories Revenue in Antifungal infection Therapeutics Business (2016-2021)
11.6.5 Kramer Laboratories Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Antifungal infection Therapeutics Introduction
11.7.4 Johnson & Johnson Revenue in Antifungal infection Therapeutics Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 ID Sigma-Aldrich Corporation
11.8.1 ID Sigma-Aldrich Corporation Company Details
11.8.2 ID Sigma-Aldrich Corporation Business Overview
11.8.3 ID Sigma-Aldrich Corporation Antifungal infection Therapeutics Introduction
11.8.4 ID Sigma-Aldrich Corporation Revenue in Antifungal infection Therapeutics Business (2016-2021)
11.8.5 ID Sigma-Aldrich Corporation Recent Development
11.9 Glenmark Pharmaceuticals
11.9.1 Glenmark Pharmaceuticals Company Details
11.9.2 Glenmark Pharmaceuticals Business Overview
11.9.3 Glenmark Pharmaceuticals Antifungal infection Therapeutics Introduction
11.9.4 Glenmark Pharmaceuticals Revenue in Antifungal infection Therapeutics Business (2016-2021)
11.9.5 Glenmark Pharmaceuticals Recent Development
11.10 Glaxosmithkline
11.10.1 Glaxosmithkline Company Details
11.10.2 Glaxosmithkline Business Overview
11.10.3 Glaxosmithkline Antifungal infection Therapeutics Introduction
11.10.4 Glaxosmithkline Revenue in Antifungal infection Therapeutics Business (2016-2021)
11.10.5 Glaxosmithkline Recent Development
11.11 Enzon Pharmaceuticals
11.11.1 Enzon Pharmaceuticals Company Details
11.11.2 Enzon Pharmaceuticals Business Overview
11.11.3 Enzon Pharmaceuticals Antifungal infection Therapeutics Introduction
11.11.4 Enzon Pharmaceuticals Revenue in Antifungal infection Therapeutics Business (2016-2021)
11.11.5 Enzon Pharmaceuticals Recent Development
11.12 Bayer Healthcare
11.12.1 Bayer Healthcare Company Details
11.12.2 Bayer Healthcare Business Overview
11.12.3 Bayer Healthcare Antifungal infection Therapeutics Introduction
11.12.4 Bayer Healthcare Revenue in Antifungal infection Therapeutics Business (2016-2021)
11.12.5 Bayer Healthcare Recent Development
11.13 Astellas Pharma
11.13.1 Astellas Pharma Company Details
11.13.2 Astellas Pharma Business Overview
11.13.3 Astellas Pharma Antifungal infection Therapeutics Introduction
11.13.4 Astellas Pharma Revenue in Antifungal infection Therapeutics Business (2016-2021)
11.13.5 Astellas Pharma Recent Development
11.14 Asperqillus
11.14.1 Asperqillus Company Details
11.14.2 Asperqillus Business Overview
11.14.3 Asperqillus Antifungal infection Therapeutics Introduction
11.14.4 Asperqillus Revenue in Antifungal infection Therapeutics Business (2016-2021)
11.14.5 Asperqillus Recent Development
11.15 Alternaria
11.15.1 Alternaria Company Details
11.15.2 Alternaria Business Overview
11.15.3 Alternaria Antifungal infection Therapeutics Introduction
11.15.4 Alternaria Revenue in Antifungal infection Therapeutics Business (2016-2021)
11.15.5 Alternaria Recent Development
11.16 Abbott Laboratories
11.16.1 Abbott Laboratories Company Details
11.16.2 Abbott Laboratories Business Overview
11.16.3 Abbott Laboratories Antifungal infection Therapeutics Introduction
11.16.4 Abbott Laboratories Revenue in Antifungal infection Therapeutics Business (2016-2021)
11.16.5 Abbott Laboratories Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Antifungal infection Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Polyenes
Table 3. Key Players of Echinocandins
Table 4. Key Players of Azoles
Table 5. Key Players of Allylamines
Table 6. Key Players of Other Drug types
Table 7. Global Antifungal infection Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Antifungal infection Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Antifungal infection Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Antifungal infection Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Antifungal infection Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Antifungal infection Therapeutics Market Share by Regions (2022-2027)
Table 13. Antifungal infection Therapeutics Market Trends
Table 14. Antifungal infection Therapeutics Market Drivers
Table 15. Antifungal infection Therapeutics Market Challenges
Table 16. Antifungal infection Therapeutics Market Restraints
Table 17. Global Antifungal infection Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Antifungal infection Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Antifungal infection Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antifungal infection Therapeutics as of 2020)
Table 20. Ranking of Global Top Antifungal infection Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Antifungal infection Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Antifungal infection Therapeutics Product Solution and Service
Table 24. Date of Enter into Antifungal infection Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Antifungal infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Antifungal infection Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Antifungal infection Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Antifungal infection Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Antifungal infection Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Antifungal infection Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Antifungal infection Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Antifungal infection Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Antifungal infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Antifungal infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Antifungal infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Antifungal infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Antifungal infection Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Antifungal infection Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Antifungal infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Antifungal infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Antifungal infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Antifungal infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Antifungal infection Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Antifungal infection Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Antifungal infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Antifungal infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Antifungal infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Antifungal infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Antifungal infection Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Antifungal infection Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Antifungal infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Antifungal infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Antifungal infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Antifungal infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Antifungal infection Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Antifungal infection Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Antifungal infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Antifungal infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Antifungal infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Antifungal infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Antifungal infection Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Antifungal infection Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Scynexis Company Details
Table 65. Scynexis Business Overview
Table 66. Scynexis Antifungal infection Therapeutics Product
Table 67. Scynexis Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million)
Table 68. Scynexis Recent Development
Table 69. Sanofi-Aventis Company Details
Table 70. Sanofi-Aventis Business Overview
Table 71. Sanofi-Aventis Antifungal infection Therapeutics Product
Table 72. Sanofi-Aventis Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million)
Table 73. Sanofi-Aventis Recent Development
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Antifungal infection Therapeutics Product
Table 77. Pfizer Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million)
Table 78. Pfizer Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Antifungal infection Therapeutics Product
Table 82. Novartis Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Novartis Recent Development
Table 84. Merck & Co Company Details
Table 85. Merck & Co Business Overview
Table 86. Merck & Co Antifungal infection Therapeutics Product
Table 87. Merck & Co Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Merck & Co Recent Development
Table 89. Kramer Laboratories Company Details
Table 90. Kramer Laboratories Business Overview
Table 91. Kramer Laboratories Antifungal infection Therapeutics Product
Table 92. Kramer Laboratories Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million)
Table 93. Kramer Laboratories Recent Development
Table 94. Johnson & Johnson Company Details
Table 95. Johnson & Johnson Business Overview
Table 96. Johnson & Johnson Antifungal infection Therapeutics Product
Table 97. Johnson & Johnson Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million)
Table 98. Johnson & Johnson Recent Development
Table 99. ID Sigma-Aldrich Corporation Company Details
Table 100. ID Sigma-Aldrich Corporation Business Overview
Table 101. ID Sigma-Aldrich Corporation Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million)
Table 102. ID Sigma-Aldrich Corporation Recent Development
Table 103. Glenmark Pharmaceuticals Company Details
Table 104. Glenmark Pharmaceuticals Business Overview
Table 105. Glenmark Pharmaceuticals Antifungal infection Therapeutics Product
Table 106. Glenmark Pharmaceuticals Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million)
Table 107. Glenmark Pharmaceuticals Recent Development
Table 108. Glaxosmithkline Company Details
Table 109. Glaxosmithkline Business Overview
Table 110. Glaxosmithkline Antifungal infection Therapeutics Product
Table 111. Glaxosmithkline Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million)
Table 112. Glaxosmithkline Recent Development
Table 113. Enzon Pharmaceuticals Company Details
Table 114. Enzon Pharmaceuticals Business Overview
Table 115. Enzon Pharmaceuticals Antifungal infection Therapeutics Product
Table 116. Enzon Pharmaceuticals Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million)
Table 117. Enzon Pharmaceuticals Recent Development
Table 118. Bayer Healthcare Company Details
Table 119. Bayer Healthcare Business Overview
Table 120. Bayer Healthcare Antifungal infection Therapeutics Product
Table 121. Bayer Healthcare Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million)
Table 122. Bayer Healthcare Recent Development
Table 123. Astellas Pharma Company Details
Table 124. Astellas Pharma Business Overview
Table 125. Astellas Pharma Antifungal infection Therapeutics Product
Table 126. Astellas Pharma Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million)
Table 127. Astellas Pharma Recent Development
Table 128. Asperqillus Company Details
Table 129. Asperqillus Business Overview
Table 130. Asperqillus Antifungal infection Therapeutics Product
Table 131. Asperqillus Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million)
Table 132. Asperqillus Recent Development
Table 133. Alternaria Company Details
Table 134. Alternaria Business Overview
Table 135. Alternaria Antifungal infection Therapeutics Product
Table 136. Alternaria Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million)
Table 137. Alternaria Recent Development
Table 138. Abbott Laboratories Company Details
Table 139. Abbott Laboratories Business Overview
Table 140. Abbott Laboratories Antifungal infection Therapeutics Product
Table 141. Abbott Laboratories Revenue in Antifungal infection Therapeutics Business (2016-2021) & (US$ Million)
Table 142. Abbott Laboratories Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antifungal infection Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Polyenes Features
Figure 3. Echinocandins Features
Figure 4. Azoles Features
Figure 5. Allylamines Features
Figure 6. Other Drug types Features
Figure 7. Global Antifungal infection Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Powders Case Studies
Figure 9. Pastes Case Studies
Figure 10. Ointments Case Studies
Figure 11. Drugs Case Studies
Figure 12. Other Applications Case Studies
Figure 13. Antifungal infection Therapeutics Report Years Considered
Figure 14. Global Antifungal infection Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Antifungal infection Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Antifungal infection Therapeutics Market Share by Regions: 2020 VS 2027
Figure 17. Global Antifungal infection Therapeutics Market Share by Regions (2022-2027)
Figure 18. Global Antifungal infection Therapeutics Market Share by Players in 2020
Figure 19. Global Top Antifungal infection Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antifungal infection Therapeutics as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Antifungal infection Therapeutics Revenue in 2020
Figure 21. Global Antifungal infection Therapeutics Revenue Market Share by Type (2016-2021)
Figure 22. Global Antifungal infection Therapeutics Revenue Market Share by Type (2022-2027)
Figure 23. North America Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Antifungal infection Therapeutics Market Share by Type (2016-2027)
Figure 25. North America Antifungal infection Therapeutics Market Share by Application (2016-2027)
Figure 26. North America Antifungal infection Therapeutics Market Share by Country (2016-2027)
Figure 27. United States Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Antifungal infection Therapeutics Market Share by Type (2016-2027)
Figure 31. Europe Antifungal infection Therapeutics Market Share by Application (2016-2027)
Figure 32. Europe Antifungal infection Therapeutics Market Share by Country (2016-2027)
Figure 33. Germany Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Antifungal infection Therapeutics Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Antifungal infection Therapeutics Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Antifungal infection Therapeutics Market Share by Region (2016-2027)
Figure 43. China Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Antifungal infection Therapeutics Market Share by Type (2016-2027)
Figure 51. Latin America Antifungal infection Therapeutics Market Share by Application (2016-2027)
Figure 52. Latin America Antifungal infection Therapeutics Market Share by Country (2016-2027)
Figure 53. Mexico Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Antifungal infection Therapeutics Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Antifungal infection Therapeutics Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Antifungal infection Therapeutics Market Share by Country (2016-2027)
Figure 59. Turkey Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Antifungal infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Scynexis Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021)
Figure 63. Sanofi-Aventis Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021)
Figure 66. Merck & Co Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021)
Figure 67. Kramer Laboratories Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021)
Figure 68. Johnson & Johnson Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021)
Figure 69. ID Sigma-Aldrich Corporation Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021)
Figure 70. Glenmark Pharmaceuticals Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021)
Figure 71. Glaxosmithkline Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021)
Figure 72. Enzon Pharmaceuticals Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021)
Figure 73. Bayer Healthcare Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021)
Figure 74. Astellas Pharma Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021)
Figure 75. Asperqillus Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021)
Figure 76. Alternaria Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021)
Figure 77. Abbott Laboratories Revenue Growth Rate in Antifungal infection Therapeutics Business (2016-2021)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

---